Date of filling in this questionnaire or last update: 12/01/2022
1. IDENTIFICATION & BASIC DESCRIPTION
Cohort name
  Australian firefighter cohort
Country
 

  • Australia

Please provide any other information on the cohort location/s if needed
  Covers employed and volunteer firefighters in most States of Australia
Name
  Deborah Glass
Institution
  Monash University
Email
  deborah.glass@monash.edu
Phone
  +61399030554
Personal website
  https://research.monash.edu/en/persons/deborah-glass
Website
 

  • https://www.monash.edu/medicine/sphpm/coeh/researchprogram/ausfireftr

Name of committee
  Monash University Human Research Ethics Committee
Contact Principal Investigator (name)
  Deborah Glass
Is this cohort part of a consortium? (name consortium)
  No.
Main aim of cohort, please briefly describe the main objectives of the cohort
  Investigate cancer incidence and mortality in a national cohort of Australian firefighters
Comparators (please select as many as appropriate)
 

  • Internal study population
  • External study population (includes SMR/SIR studies)

Inclusion criteria
  Employed or volunteer firefighter for at least three months
Exclusion criteria
  Employed for less than three months
Enrollment
  Completed
Age range at entry (main cohort)
 

Minimum Maximum Mean
34

Men at enrollment
  30057
Participation rate at enrollment (if known)
  100
Comments
  Personal identifiers and employment data retrieved from HR databases
2. OUTCOME FOLLOW-UP
Type of data for outcome follow-up (please select as many as appropriate)
 

  • Death certificate
  • Disease incidence records
  • Use of registers (specify)

Death certificate (specify)
 

  • Cause of death

Disease incidence records (specify)
 

  • Cancer incidence

Specify: Use of registers
 

  • Australian Cancer database and National Death Index

First follow-up period (provide year)
  2011
Last follow-up period (provide year)
  2011
Number of follow-ups after baseline (provide number)
  1
Participation at last follow-up (if known)
  100
3. OCCUPATIONAL EXPOSURES
Source of exposure data collected (please select as many as appropriate)
 

  • Job-employment records

Occupational history/time frame
  Lifetime
Occupational coding performed
  Yes
Occupation (specify coding system used)
 

  • ASCO

Industry (specify coding system used)
 

  • Not applicable

Methods for exposure assessment (please select as many as appropriate)
 

  • Expert assessment
  • Other (specify)

Specify: Other
  Incident database
Main categories
 

  • Dusts and fibres

Dusts and fibres | Organic dusts
 

  • Other (specify)

Dusts and fibres | Organic dusts | Specify: Other
  Particulate from fires
Dusts and fibres | Other
 

  • Other

Dusts and fibres | Other | Specify: Other
  Other pyrolysis products during fires
4. OUTCOMES EVALUATED
Follow-up - type of outcome data collected (select more than one if applicable)
 

  • Death certificates
  • Registry-based

Registry-based
 

  • Cancer incidence
  • Mortality register

Outcome type (please select as many as appropriate)
 

  • Mortality
  • Morbidity

Diagnostic groups based on ICD10
 

  • C + D Neoplasms
  • Other (specify)

Other (specify)
  All causes of death
C + D Neoplasms
 

  • Benign neoplasm
  • Carcinoma in situ
  • Leukemia
  • Malignant neoplasms gastro intes. system including liver, gall bladder, pancreas
  • Malignant neoplasm lung
  • Mesothelioma
  • Other malignant neoplasm of respiratory and intrathoracic organs, heart, pleura
  • Malignant neoplasm of bone and articular cartilage
  • Melanoma and other malignant neoplasms of skin
  • Neoplasms connective and soft tissue including nerves
  • Malignant neoplasm of breast
  • Malignant neoplasms, females gynecological
  • Malignant neoplasms of male genital organs
  • Malignant neoplasm of urinary tract and kidney
  • Malignant neoplasms of eye, brain and other parts of central nervous system
  • Malignant neoplasms of thyroid and other endocrine glands
  • Malignant neoplasms of ill-defined, secondary and unspecified sites
  • Malignant neoplasm without specification of site including excl. leukemia
  • Other, please state

6. Other Information
 

  • Smoking

Possibility for linkage to data registries/data enrichment via data linkage
 

  • Cancer incidence
  • Disease specific clinical database
  • Hospital discharge
  • Medication usage
  • Mortality register

Please describe plans that are funded or most likely to be funded
  Recent grant awarded from the Australian National Health and Medical Research Council to do a follow up cancer and mortality linkage and investigate PFAS exposure (firefighter foams).